Exceptional people – not code or capital – build transformative, category-defining companies.
About
We back deeply independent thinkers with audacious dreams and relentless determination.
Most importantly, we partner with special founders who have the rare ability to do two really hard things simultaneously:
- anticipate what will move society and culture forward in the future (we call this: “time jumping”, and it’s what makes certain founders “special”), and
- build and lead a transformative, category-defining company, from the outset through to massive scale.
We focus on a company’s long-term impact and typically invest at an early stage. We often work alongside founders at the incubation stage as an inception partner, as well as providing strategic insights and a willing sounding board to founders throughout the entire company lifecycle.
Wormhole Capital is the investment arm of Vivek Garipalli’s family office. While sector-agnostic, we seek business models that inherently propel a positive flywheel effect.
Our Name
In 1935, Albert Einstein and physicist Nathan Rosen used the theory of general relativity to propose the existence of wormholes. These tunnel-like passages (also known as Einstein-Rosen “bridges”) connect two different points in space-time, theoretically creating a shortcut that reduces travel time and distance through superluminal (faster-than-light) motion. In other words: time travel.
Portfolio
Latest Investment
A new model for fertility care [Seed]
Private equity-focused financial consulting and technology firm [Series A]
Gourmet organic candy that serves a higher purpose [Seed]
Transforming defense capabilities with advanced technology
Simple, tech-enabled health plans for the modern employee [Seed]
Deploy a secure, HIPAA-compliant app from day one [Seed]
Bringing you a better glass of wine, no matter where you are [Seed]
Improving patient affordability, access, and care adherence [Series A]
Use AI to manage enterprise AI workflows at scale [Seed]
Physical automation to transform industry and move the world
Technology company committed to improving health equity for seniors [Inception]
Biotechnology and genetic engineering company
All-in-one practice operations platform for Nurse Practitioners [Seed]
Automated medical record retrieval platform for providers and payers [Seed]
Specialty kidney care provider of integrated nephrology and dialysis care [Seed]
Energy-first artificial intelligence infrastructure and cloud platform company
A new model for venture capital in biotech [Seed]
Document automation and data extraction using AI [Series A]
Empowers smarter healthcare decisions with better evidence and insights [Series A]
Friendship and support through femalehood from fertility to menopause [Seed]
The Smart Menstrual Solution [Seed]
The leading expert-led and technology-powered employee benefit caregiving solution [Series A]
The first digital platform for health plan administration [Series A]
Medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease [Series A]
Vertical SaaS platform for small business owners in the beauty and wellness space [Seed]
Medication and prescription optimisation platform [Inception]
Healthcare invoice management and reimbursement platform [Seed]
Improving the way people purchase and access healthcare [Series A]
Mental healthcare system provider that helps patients connect with therapists and submit insurance claims online [Seed]
AI medical scribe for all clinicians [Series A]
Data governance platform for organizations to automate data access control, security, and privacy compliance [Series B]
Redefining the delivery of mental health care services for schools and communities [Seed]
Redesigning the medical malpractice industry [Inception]
Health and technology company providing fertility, gynaecology, and family-building care [Seed]
Provides a complete compliance platform that automates workflows in a single, collaborative space [Seed]
AI-powered contract review platform [Seed]
Primary care co-pilot powered by health data & top clinicians [Seed]
Brain-computer interface technology in everyday consumer products [Seed]
Addressing the complex challenges of opioid use disorder [Inception]
Building the world’s first bone marrow bank to treat blood cancers [Seed]
Provider of medical equipment ordering software [Growth]
API designed for healthcare innovators that gives access to vital medical data [Series A]
Alternative lodging service that operates pop-up hotels in newly built, luxury apartment buildings [Seed]
Next-generation transaction intelligence platform [Seed]
Building an “artificial general engineer” to revolutionize physical design and manufacturing [Series B]
Digital closing platform for real estate and mortgage companies to provide simple, secure homebuying experiences [Series B]
Developing open foundation models and software agents for AI-assisted software development [Series B]
Health insurance company that uses software, data science and telemedicine to make health insurance delightful, affordable and easier to access in Nigeria [Series A]
Digitizing the pharmaceutical supply chain in Africa [Seed]
Accelerates the development of artificial intelligence [Seed]
Automates the management of healthcare simulation, training and compliance programs [Seed]
Brings order, trust, and predictability to the clinical supply chain [Seed]
Making humanity multiplanetary
Operating platform for retailers to capture digital advertising dollars and build customer loyalty [Seed]
A new model for fertility care [Seed]
Evidence-based mental health tools that are accessible and enjoyable [Series A]
Provider of oncology care management solutions [Inception]
Global concierge health services [Seed]
The vehicle secured credit card [Seed]
Team
Vivek Garipalli
Vivek Garipalli is an entrepreneur who has founded and invested in various companies including Clover Health, a healthcare technology company with the stated mission to improve every life. He founded Clover Health in 2014 and served as CEO until December 2022, and continues as Executive Chair of the Board and largest shareholder.
Prior to Clover, Vivek co-founded both CarePoint Health and Ensemble Health. CarePoint is a healthcare system that offers acute care and emergency services to a large, historically underserved population in Hudson County, New Jersey. In May 2022, the ownership of the three CarePoint hospitals was contributed to a community-based non-profit called CarePoint Health Systems.
Ensemble is a national healthcare revenue cycle services company. The experience of building these two companies — and seeing firsthand the misalignment between healthcare providers, insurance companies, and most importantly, consumers — ultimately inspired the founding of Clover Health.
With Flatiron Health, Vivek saw the opportunity to leverage technology to help align mission with business model. At Flatiron, he entered as an early investor, and advised on their strategy and business model, including leading the acquisition of its data platform, Altos. He sat on the board through to its sale to Roche in 2018 and currently serves / has served on the boards of Cityblock Health, Clover Health, Dr.Evidence, Flatiron Health, Medically Home, and Thyme Care.
Vivek began his career in finance, holding roles at Credit Suisse First Boston, J.P. Morgan Partners and Blackstone Group.
Nick Hyde
Nick is a partner and co-founder of Wormhole Capital. In addition to managing Wormhole’s portfolio and leading new investments, Nick serves on the board of directors of Credo, GoldenScript and The American Baby Company.
In keeping with Wormhole’s mission to partner with exceptional people, Nick loves working closely with founders from the earliest stages and always brings a first-principles approach to company-building and investing.
Prior to Wormhole, Nick was the managing partner and co-founder of Mendacre, a seed fund founded in 2017 that has invested in several early-stage technology companies across the United States.
Nick began his career as a corporate attorney at Slaughter and May in London and Cravath, Swaine & Moore LLP in New York, where he focused on public and private mergers and acquisitions, initial public offerings and follow-on offerings, private equity and venture capital.
Spotlight
Interview with Matt Angle, CEO and Founder of Paradromics
Paradromics Achieves Real-Time Speech with the Connexus® Brain-Computer Interface
When the first participant in Paradromics’ clinical study switched to free speech, the sentence she chose was “Okay, I have a lot to say.” Connexus decoded it in real time without error. The moment marks a first demonstration of self-directed communication through the company’s fully implantable, investigational system.
Thyme Care Closes $125M+ Series E and Establishes Thyme Companies
Since its inception, Thyme Care has worked to make the experience of cancer more coordinated and less costly for the people living through it. A $125 million-plus Series E led by Morgan Health, at a valuation above $2 billion, now supports that work across more than 10.5 million covered lives in all 50 states. The company is also launching Thyme Companies, a new parent entity that will build independent businesses aimed at specific bottlenecks in oncology. The first of these is expected later this year.
Cityblock Health Raises $116M Series E and Agrees to Acquire Homeward
Cityblock spent nearly a decade learning how to care for urban Medicaid and dual-eligible members with complex health and social needs. It has now signed a definitive agreement to acquire Homeward Health, which extends that model into rural Medicare Advantage. The $116 million Series E, led by General Catalyst, brings the combined company closer to serving the 120 million Americans who rely on government-funded healthcare.
Angle Health Announces $600M Financing at a $2.7B Valuation
Angle Health was built to give small businesses health benefits that are both affordable and easy to use. It now serves more than 5,000 employers across 47 states and has been profitable for four consecutive quarters. The financing combines a $200 million Series C, led by Vitruvian Partners, with a $400 million tender offer.
GlossGenius Becomes Genius AI with Series D at a $1.15B Valuation
Twin founders Danielle and Leah Cohen-Shohet started out simplifying the business of beauty. Their platform now supports more than 125,000 in-person service businesses. Alongside a $44 million Series D led by Lux Capital, the company has taken a new name, Genius AI, to match its larger ambition of building agentic software for the entire service economy.